Equillium, Inc. Files 8-K on Security Holder Vote Matters
Ticker: EQ · Form: 8-K · Filed: May 23, 2024 · CIK: 1746466
| Field | Detail |
|---|---|
| Company | Equillium, INC. (EQ) |
| Form Type | 8-K |
| Filed Date | May 23, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: EQ
TL;DR
Equillium (EQ) filed an 8-K for a security holder vote. Nothing major disclosed yet.
AI Summary
Equillium, Inc. filed an 8-K on May 23, 2024, reporting on a submission of matters to a vote of security holders. The filing date for the report is May 22, 2024. The company is incorporated in Delaware and its principal executive offices are located in La Jolla, CA.
Why It Matters
This filing indicates that Equillium, Inc. is engaging in corporate governance activities, specifically related to matters requiring a vote from its security holders.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure regarding a vote of security holders and does not appear to contain significant new financial or operational information.
Key Players & Entities
- Equillium, Inc. (company) — Registrant
- May 22, 2024 (date) — Date of earliest event reported
- May 23, 2024 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- La Jolla, CA (location) — Address of Principal Executive Offices
FAQ
What specific matters are being submitted for a vote of Equillium's security holders?
The filing states it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters within the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on May 22, 2024.
What is Equillium, Inc.'s standard industrial classification?
Equillium, Inc.'s standard industrial classification is 'PHARMACEUTICAL PREPARATIONS [2834]'.
Where are Equillium, Inc.'s principal executive offices located?
Equillium, Inc.'s principal executive offices are located at 2223 Avenida de la Playa Suite 105, La Jolla, CA 92037.
What is the SEC file number for Equillium, Inc.?
The SEC file number for Equillium, Inc. is 001-38692.
Filing Stats: 932 words · 4 min read · ~3 pages · Grade level 12.2 · Accepted 2024-05-23 17:00:15
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share EQ The Nasdaq Capital Mar
Filing Documents
- eq-20240522.htm (8-K) — 80KB
- 0000950170-24-064016.txt ( ) — 196KB
- eq-20240522.xsd (EX-101.SCH) — 27KB
- eq-20240522_htm.xml (XML) — 5KB
07 Submission of Matters to a Vote of Security Holders
Item 5.07 Submission of Matters to a Vote of Security Holders. On May 22, 2024, Equillium, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). As of April 1, 2024, the record date for the Annual Meeting (the "Record Date"), 35,254,752 shares of the Company's common stock were outstanding and entitled to vote at the Annual Meeting. A summary of the matters voted upon by stockholders at the Annual Meeting is set forth below. A total of 25,426,317 shares of the Company's common stock were present at the Annual Meeting or represented by proxy, which represents approximately 72% of the shares of the Company's common stock outstanding as of the Record Date. Proposal 1. Election of directors. The Company's stockholders elected the three persons listed below as Class III directors, each to serve until the Company's 2027 Annual Meeting of Stockholders and until his or her respective successor has been duly elected and qualified, or until his or her earlier death, resignation or removal. The final voting results are as follows: Name Votes For Votes Withheld Broker Non- Votes Daniel M. Bradbury 15,911,310 325,969 9,189,038 Martha J. Demski 15,971,815 267,830 9,186,672 Mark Pruzanski, M.D. 15,834,792 403,119 9,188,406 Proposal 2. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split. The Company's stockholders approved an amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split of the Company's common stock at a ratio in the range of 1-for-2 to 1-for-10, inclusive, with such ratio to be determined in the discretion of the Company's Board of Directors and with such reverse stock split to be effected at such time and date, if at all, as determined by the Company's Board of Directors in its sole discretion. The final voting results are as follows: Votes For Votes Against Abs